檢索結果 - Pablo Hernández-Luis
- Showing 1 - 2 results of 2
-
1
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers 由 Gemma Moncunill, Ruth Aguilar, Marta Ribes, Natalia Ortega, Rocío Rubio, Gemma Salmerón, María José Molina, Marta Vidal, Diana Barrios, Robert A. Mitchell, Alfons Jiménez, Cristina Castellana, Pablo Hernández-Luis, Pau Rodó, Susana Méndez, Anna Llupià, Laura Puyol, Natalia Rodrigo Melero, Carlo Carolis, Alfredo Mayor, Luís Izquierdo, Pilar Varela, Antoni Trilla, Anna Vilella, Sónia Barroso, Ana Angulo, Pablo Engel, Marta Tortajada, Alberto L. García‐Basteiro, Carlota Dobaño
出版 2022Artigo -
2
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses 由 Natalia Ortega, Marta Ribes, Marta Vidal, Rocío Rubio, Ruth Aguilar, Sarah Williams, Diana Barrios, Selena Alonso, Pablo Hernández-Luis, Robert A. Mitchell, Chenjerai Jairoce, Angeline Cruz, Alfons Jiménez, Rebeca Santano, Susana Méndez, Montserrat Lamoglia, Neus Rosell, Anna Llupià, Laura Puyol, Jordi Chi, Natalia Rodrigo Melero, Daniel Parras, Pau Serra, Edwards Pradenas, Benjamin Trinité, Julià Blanco, Alfredo Mayor, Sónia Barroso, Pilar Varela, Anna Vilella, Antoni Trilla, Pere Santamaría, Carlo Carolis, Marta Tortajada, Luís Izquierdo, Ana Angulo, Pablo Engel, Alberto L. García‐Basteiro, Gemma Moncunill, Carlota Dobaño
出版 2021Artigo
相關主題
Antibody
Antigen
Immunology
Internal medicine
Medicine
Virology
Adverse effect
Asymptomatic
Avidity
Cohort
Coronavirus
Coronavirus disease 2019 (COVID-19)
Disease
Immunoglobulin G
Infectious disease (medical specialty)
Neutralizing antibody
Serology
Seroprevalence
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Vaccination
Vaccine efficacy